Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amneal Pharmaceuticals Inc shares valued at $663,065 were purchased by Shah Nikita on Aug 14 ’25. At $9.25 per share, Shah Nikita acquired 71,694 shares.
Also, Shah Nikita sold 50,000 shares, netting a total of over 452,000 in proceeds. Following the sale of shares at $9.04 each, the insider now holds 338,929 shares.
Before that, Daly Jason B. had sold 22,000 shares from its account. In a trade valued at $199,100, the EVP, Chief Legal Officer traded Amneal Pharmaceuticals Inc shares for $9.05 each. Upon closing the transaction, the insider’s holdings decreased to 22,000 shares, worth approximately $99590.34000000001.
As published in their initiating research note from Goldman on June 06, 2025, Amneal Pharmaceuticals Inc [AMRX] has been a Buy and the price target has been revised to $12. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late February. As of September 06, 2024, JP Morgan has increased its “an Underweight” rating to a “Neutral” for AMRX.
Analyzing AMRX Stock Performance
On last trading session, Amneal Pharmaceuticals Inc [NASDAQ: AMRX] plunged -0.11% to $9.39. The stock’s lowest price that day was $9.15, but it reached a high of $9.41 in the same session. During the last five days, there has been a surge of approximately 14.37%. Over the course of the year, Amneal Pharmaceuticals Inc shares have jumped approximately 24.54%. Shares of the company reached a 52-week high of $9.41 on 08/14/25 and a 52-week low of $6.68 on 04/10/25.
Support And Resistance Levels for Amneal Pharmaceuticals Inc (AMRX)
According to the 24-hour chart, there is a support level at 9.22, which, if violated, would cause prices to drop to 9.06. In the upper region, resistance lies at 9.48. The next price resistance is at 9.58. RSI (Relative Strength Index) is 77.19 on the 14-day chart, showing overbought technical sentiment.
Is Amneal Pharmaceuticals Inc subject to short interest?
Stocks of Amneal Pharmaceuticals Inc saw a sharp steep in short interest on 2025-07-31 dropping by -1.63 million shares to 4.93 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 6.55 million shares. A decline of -32.99% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.55 of the overall float, the days-to-cover ratio (short ratio) decline to 3.55.
Which companies own the most shares of Amneal Pharmaceuticals Inc (AMRX)?
In terms of Amneal Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 11 in the next 12 months, up nearly 17.02% from the previous closing price of $9.4. Analysts anticipate Amneal Pharmaceuticals Inc stock to reach 11 by 2025, with the lowest price target being 11. In spite of this, 1 analysts ranked Amneal Pharmaceuticals Inc stock as Buy at the end of 2025. On March 08, 2021, Goldman assigned a price target of “a Buy” to the stock and upgraded coverage with a $6.50.
